WE MOVE
204 West 84th Street
New York, NY 10024
E-mail: wemove@wemove.org
wemove.org • mdvu.org

Stay Connected Research News Chat Discussion Forum Advocacy and Support Organizations Patient Meeting Calendar Movement Disorder Glossary Movement Disorders Virtual University Linkage Library
WE MOVE

Treatment of Pediatric Movement Disorders

Medication: Channel Modulators

Some paroxysmal movement disorders, including periodic paralysis, episodic ataxia, and alternating hemiplegia, are probably caused by abnormalities in the channels that transport small molecules such as potassium, sodium, or calcium across cell membranes. Therefore, these disorders may respond to medications that affect the behavior of these channels. Such medications include acetazolamide (Diamox®), carbamazepine (Tegretol®), topiramate (Topamax®), and calcium-channel blockers, (e.g., flunarizine [Sibelium®, not available in the US], nifedipine [Procardia® Adalat®], and others). Common side effects include drowsiness, low blood pressure, and nausea.